Manufacturing of [14C]-Labeled Drug Substance and Drug Product Utilized in Clinical Research: A Case Study of Omecamtiv Mecarbil

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|5|609-615

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.5, 2016-02, pp. : 609-615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stable isotope-labeled excipients for drug product identification and counterfeit detection

By Felton Linda A.   Shah Punit P.   Sharp Zachary   Atudorei Viorel   Timmins Graham S.  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 1, 2011-01 ,pp. : 88-92

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Drug Monitoring in Clinical Research

By Neef Cees  

Pharmaceutical Medicine, Vol. 22, Iss. 4, 2008-01 ,pp. : 235-244

Adis International

Access to resources Recommend Favorite

Model-Guided Design Space Development for a Drug Substance Manufacturing Process

By Burt Justin  

Journal of Pharmaceutical Innovation, Vol. 6, Iss. 3, 2011-09 ,pp. : 181-192

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Exploratory Drug Metabolism and Pharmacokinetics in New Drug Research: Case Study-Selection of a Thrombin Receptor Antagonist for Development

By  

Current Pharmaceutical Design, Vol. 15, Iss. 19, 2009-07 ,pp. : 2262-2269

Bentham Science Publishers

Access to resources Recommend Favorite

14C-labeled Pulegone and Metabolites Binding to α2u-globulin in Kidneys of Male F-344 Rats

By Ferguson Ling-Jen Chen   Lebetkin Edward H.   Lih Fred B.   Tomer Kenneth B.   Parkinson Horace D.   Borghoff Susan J.   Burka Leo T.  

Journal of Toxicology and Environmental Health, Vol. 70, Iss. 17, 2007-01 ,pp. : 1416-1423

Taylor & Francis Ltd

Access to resources Recommend Favorite